| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $76.3M | +5.3% |
| Cost of Revenue | $45.2M | +10.2% |
| Gross Profit | $31.1M | -1.0% |
| R&D Expense | $2.2M | +19.3% |
| SG&A Expense | $3.3M | +33.6% |
| Operating Income | $13.0M | -21.7% |
| Pre-tax Income | $13.0M | -21.7% |
| Income Tax | $3.0M | -24.7% |
| Net Income | $10.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | +41.4% |
| Accounts Receivable | $12.8M | +1.4% |
| Inventory | $22.8M | +8.2% |
| Current Assets | $47.7M | +6.9% |
| Total Assets | $51.9M | +5.6% |
| Current Liabilities | $11.2M | -40.1% |
| Long-term Debt | $250K | -8.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.1M | +10.9% |
| Investing Cash Flow | -$1.0M | +8.3% |
| Financing Cash Flow | $289K | -51.5% |
| -20.8% |
| EPS (Basic) | $1.71 | -25.3% |
| EPS (Diluted) | $1.62 | -21.7% |
| Stockholders' Equity |
| $39.7M |
| +38.7% |